STAT+: At ASCO, talk of barriers to cancer care, new treatments, and other big takeaways
We asked Brian Wolpin, the presenter for yesterday’s plenary on the daraxonrasib pancreatic cancer study, about the sustained standing ovation that interrupted his remarks. “Honestly, it was tough to hold it together in